$2.25
0.031.35%
Pre-Market: 8:25 AM EDT
Comments
Loading...
Inovio Pharmaceuticals (INO) Forecast
NewsEarningsInovio Pharmaceuticals (INO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestInovio Pharmaceuticals (NASDAQ:INO) Stock Quotes, Forecast and News Summary
Inovio Pharmaceuticals Stock (NASDAQ: INO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Inovio Pharmaceuticals (INO) stock?
You can purchase shares of Inovio Pharmaceuticals (NASDAQ:INO) through any online brokerage.
Who are Inovio Pharmaceuticals (INO) competitors?
Other companies in Inovio Pharmaceuticals’s space includes: Adverum Biotechnologies (NASDAQ:ADVM), OncoCyte (NASDAQ:OCX), bluebird bio (NASDAQ:BLUE), Inozyme Pharma (NASDAQ:INZY) and Burning Rock Biotech (NASDAQ:BNR).
What is the forecast, or price target, for Inovio Pharmaceuticals (INO) stock?
Inovio Pharmaceuticals has a consensus price target of $14.86.
What is the current price for Inovio Pharmaceuticals (INO)?
The stock price for Inovio Pharmaceuticals (NASDAQ: INO) is $2.2499 last updated February 20, 2025 at 8:25 AM EST.
Does Inovio Pharmaceuticals (INO) pay a dividend?
There are no upcoming dividends for Inovio Pharmaceuticals.
When is Inovio Pharmaceuticals (NASDAQ:INO) reporting earnings?
Inovio Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is Inovio Pharmaceuticals (INO) going to split?
There is no upcoming split for Inovio Pharmaceuticals.
What sector and industry does Inovio Pharmaceuticals (INO) operate in?
Inovio Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.